Talon Resources Targets Ontario Gold Growth After AIM Move and Eagle Lake Acquisition, CEO Says. Watch here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksQuadrise Regulatory News (QED)

Share Price Information for Quadrise (QED)

Share Price is delayed by 15 minutes
Get Live Data
1.80    0.05 (2.86%)
Bid:
1.65
Ask:
1.80
Spread: 0.15 (9.091%)
Market Cap: £36.11m
QED Live PriceLast checked at - London Stock Exchange

Intraday Quadrise Share Chart

Disposal

11 Sep 2009 07:00

RNS Number : 8892Y
Quintain Estates & Development PLC
11 September 2009
 



11 September 2009 

Quintain Estates & Development plc

("Quintain" / "Company" / "Group")

QUINTAIN REPATRIATES A FURTHER £31.3 MILLION OF CASH

Quintain announces the sale of units in The Quercus Healthcare Property Partnership ("Quercus" / the "Fund"for a total cash consideration of £31.3 million. The units have been sold to a number of UK institutional pension funds through the anonymous matched bargain dealing facility provided by Aviva Investors, Quintain's partner in the Fund.

This transaction was undertaken as part of Quintain's strategy to repatriate cash and reduce gearing, thereby enhancing the Company's financial flexibility. The proceeds of the disposal bring the total amount of cash repatriated since 1 April 2009 to over £42 million, representing 85% of the £50 million Quintain had targeted to raise in the year to 31 March 2010. The total cash repatriated by the Group since 1 April 2008 is now £140 million. 

Quercus is the largest fund within Quintain Fund Management. As at 30 June 2009, it had £759.9 million in funds under management and owned 264 assets, comprising nursing and residential care homes for the elderly, specialist care homes for those with long term disabilities, private hospitals, and care villages. The units were sold at a 12% discount to the Fund's reported NAV at July and a discount to Quintain's March valuation of £10.8mrepresenting a loss against book cost of £1.8 million. In the last twelve months, the units delivered £2.5 million of income to the Group

As a result of this disposalQuintain's total holding in Quercus is reduced from 25.4% to 16% and the number of investors in the Fund has increased to 50.

Rebecca Worthington, Finance Director of Quintain, commented: 

"This disposal represents another important milestone in our cash repatriation programme, taking the total raised to 85% of the £50 million we intend to repatriate by 31 March 2010 and thereby further enhancing Quintain's financial flexibility and control over interest costs."

For further information, please contact:

Quintain Estates & Development plc

Rebecca Worthington / Tonianne Dwyer / Cressida Curtis

Tel: +44 (0) 20 7495 8968

Financial Dynamics

Stephanie Highett / Dido Laurimore / Laurence Jones 

Tel: +44 (0) 20 7831 3113

Notes to Editors

Quintain Fund Management ("QFM") uses specialist property expertise to create value in its funds operating in three sectors with high barriers to entry: healthcare (Quercus), student accommodation (iQ) and science parks (Quantum). Each fund is underpinned by strong demographics such as an ageing population and increasing numbers of people entering higher education. The Funds interact with Quintain's other businesses, taking space on our major schemes, using the asset management skills within the Investment Portfolio and generating income that is used across the Group.

As at 31 March 2009, QFM's funds under management were £980 million.

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
DISILFSRAIIILIA
Date   Source Headline
14th May 20104:34 pmRNSDirector/PDMR Shareholding
6th May 201011:53 amRNSHolding(s) in Company
4th May 201010:48 amRNSNotice of Results
28th Apr 20109:04 amRNSBarclaycard Partnership at Wembley Arena
20th Apr 201010:41 amRNSHolding(s) in Company
13th Apr 201012:46 pmRNSDirector/PDMR Shareholding
12th Apr 20104:10 pmRNSHolding(s) in Company
31st Mar 20107:00 amRNSPre-close statement
26th Mar 201011:24 amRNSDirector/PDMR Shareholding
22nd Mar 20109:22 amRNSFund Management Presentation
26th Feb 20102:39 pmRNSDirector/PDMR Shareholding
18th Feb 20107:00 amRNSDirectorate Change
16th Feb 201012:43 pmRNSDirector/PDMR Shareholding
21st Jan 20102:51 pmRNSDirector/PDMR Shareholding
21st Jan 20107:01 amRNSInterim Management Statement
21st Jan 20107:00 amRNSDirectorate Change
29th Dec 20095:06 pmRNSHolding(s) in Company
22nd Dec 20093:21 pmRNSHolding(s) in Company
15th Dec 200911:07 amRNSHolding(s) in Company
15th Dec 200910:59 amRNSDirector/PDMR Shareholding
14th Dec 20093:29 pmRNSDirector/PDMR Shareholding
11th Dec 20093:18 pmRNSHolding(s) in Company
11th Dec 20093:10 pmRNSDirector/PDMR Shareholding
10th Dec 20091:48 pmPRNDisclosure of Short Position
10th Dec 20091:48 pmPRNDisclosure of Short Position
10th Dec 20091:17 pmRNSDirector/PDMR Shareholding
10th Dec 20099:29 amRNSTotal Voting Rights
10th Dec 20099:15 amRNSHolding(s) in Company
10th Dec 20099:13 amRNSRESULT OF RUMP PLACING
10th Dec 20097:00 amRNSRESULT OF RIGHTS ISSUE
9th Dec 20093:54 pmPRNDisclosure of Short Position - TR3
9th Dec 20093:20 pmRNSDisclosure of Short Position
8th Dec 20099:38 amRNSDirector/PDMR Shareholding
7th Dec 20092:32 pmRNSHolding(s) in Company
7th Dec 20092:18 pmPRNDisclosure of Short Position - TR3
7th Dec 20092:14 pmBUSDisclosure of Short Position
7th Dec 200912:47 pmPRNDisclosure of Short Position - TR3
4th Dec 20095:46 pmRNSDisclosure of Short Position
4th Dec 20092:29 pmBUSDisclosure of Short Position
4th Dec 200910:11 amPRNShort Selling Disclosure
4th Dec 200910:10 amPRNShort Selling Disclosure
3rd Dec 20094:34 pmPRNDisclosure of Short Position - TR3
3rd Dec 200910:00 amPRNShort Selling Disclosure
3rd Dec 20099:55 amPRNShort Selling Disclosure
2nd Dec 20094:03 pmRNSHolding(s) in Company
2nd Dec 20091:55 pmBUSDisclosure of Short Position
2nd Dec 200912:13 pmBUSDisclosure of Short Position
1st Dec 200912:45 pmRNSDisclosure of Short Position
26th Nov 20093:29 pmRNSDirector/PDMR Shareholding
26th Nov 20091:06 pmBUSDisclosure of Short Position

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.